H. Ç. Arca, L. I. Mosquera-giraldo, D. Dahal, L. S. Taylor, and K. J. Edgar, Multidrug, Anti-HIV amorphous solid dispersions: nature and mechanisms of impacts of drugs on each other's solution concentrations, Mol. Pharm, vol.14, issue.11, pp.3617-3627, 2017.

A. Singh and G. , Van den Mooter, Spray drying formulation of amorphous solid dispersions, Adv. Drug Deliv. Rev, vol.100, pp.27-50, 2016.

S. Baghel, H. Cathcart, and N. J. O'reilly, Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs, J. Pharm. Sci, vol.105, issue.9, pp.2527-2544, 2016.

B. B. Patel, J. K. Patel, S. Chakraborty, and D. Shukla, Revealing facts behind spray dried solid dispersion technology used for solubility enhancement, Saudi Pharm. J, vol.23, issue.4, pp.352-365, 2015.

Y. Sun, J. Tao, G. G. Zhang, and L. Yu, Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc, J. Pharm. Sci, vol.99, issue.9, pp.4023-4031, 2010.

K. Wlodarski, W. Sawicki, A. Kozyra, and L. Tajber, Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA, Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV, vol.96, pp.237-246, 2015.

J. Ihli, A. N. Kulak, and F. C. Meldrum, Freeze-drying yields stable and pure amorphous calcium carbonate (ACC), vol.49, pp.3134-3136, 2013.

Y. Kojo, S. Matsunaga, H. Suzuki, H. Sato, Y. Seto et al., Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.97, pp.55-61, 2017.

S. O. Kyeremateng, M. Pudlas, and G. H. Woehrle, A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations, J. Pharm. Sci, vol.103, issue.9, pp.2847-2858, 2014.

J. Thiry, Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination, Int. J. Pharm, vol.515, issue.1-2, pp.114-124, 2016.

T. Xie and L. S. Taylor, Dissolution performance of high drug loading celecoxib amorphous solid dispersions formulated with polymer combinations, Pharm. Res, vol.33, issue.3, pp.739-750, 2016.

V. Caron, Amorphous solid dispersions of sulfonamide/soluplus® and sulfonamide/PVP prepared by ball milling, AAPS PharmSciTech, vol.14, issue.1, pp.464-474, 2013.

A. Mahieu, J. Willart, E. Dudognon, F. Danède, and M. Descamps, A new protocol to determine the solubility of drugs into polymer matrixes, Mol. Pharm, vol.10, issue.2, pp.560-566, 2013.

K. Semjonov, The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.97, pp.237-246, 2017.

J. N. Pawar, Development of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studies, Asian J. Pharm. Sci, vol.11, issue.3, pp.385-395, 2016.

R. Ghanavati, A. Taheri, and A. Homayouni, Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier, Mater. Sci. Eng. C, vol.72, pp.501-511, 2017.

S. B. Murdande, M. J. Pikal, R. M. Shanker, and R. H. Bogner, Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement, Pharm. Dev. Technol, vol.16, issue.3, pp.187-200, 2011.

N. Shah, H. Sandhu, D. S. Choi, H. Chokshi, and A. W. Malick, Amorphous Solid Dispersions: Theory and Practice, 2014.

M. M. Knopp, Comparative study of different methods for the prediction of drug-polymer solubility, Mol. Pharm, vol.12, issue.9, pp.3408-3419, 2015.

P. J. Marsac, S. L. Shamblin, and L. S. Taylor, Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility, Pharm. Res, vol.23, issue.10, pp.2417-2426, 2006.

J. Tao, Y. Sun, G. G. Zhang, and L. Yu, Solubility of small-molecule crystals in polymers: d-Mannitol in PVP, Indomethacin in PVP/VA, and Nifedipine in PVP/VA, Pharm. Res, vol.26, issue.4, pp.855-864, 2008.

K. Lehmkemper, S. O. Kyeremateng, O. Heinzerling, M. Degenhardt, and G. Sadowski, Long-term physical stability of PVP-and PVPVA-amorphous solid dispersions, Mol. Pharm, vol.14, issue.1, pp.157-171, 2017.

N. Kumar and K. Biswas, Cryomilling: an environment friendly approach of preparation large quantity ultra refined pure aluminium nanoparticles, J. Mater. Res. Technol, 2017.

Z. Yang, K. Nollenberger, J. Albers, and S. Qi, Molecular implications of drug-polymer solubility in understanding the destabilization of solid dispersions by milling, Mol. Pharm, vol.11, issue.7, pp.2453-2465, 2014.

A. Sosnik and K. P. Seremeta, Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers, Adv. Colloid Interface Sci, vol.223, pp.40-54, 2015.

R. N. Kamble, P. P. Mehta, and A. Kumar, Efavirenz self-nano-emulsifying drug delivery system. in vitro and in vivo evaluation, AAPS PharmSciTech, vol.17, issue.5, pp.1240-1247, 2016.

D. A. Chiappetta, C. Hocht, C. Taira, and A. Sosnik, Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability, Nanomed, vol.5, issue.1, pp.11-23, 2009.

W. Hiv/aids' and . Health-organization, , p.29, 2018.

C. R. Hoffmeister, Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.99, pp.310-317, 2017.

S. K. Sathigari, V. K. Radhakrishnan, V. A. Davis, D. L. Parsons, and R. J. Babu, Amorphous-state characterization of efavirenz-polymer hot-melt extrusion systems for dissolution enhancement, J. Pharm. Sci, vol.101, issue.9, pp.3456-3464, 2012.

. Efavirenz-|-c14h9clf3no2--pubchem, , p.8, 2018.

, Soluplus -For better solubility & bioavailability', p.8, 2018.

J. A. Baird and L. S. Taylor, Evaluation of amorphous solid dispersion properties using thermal analysis techniques, Adv. Drug Deliv. Rev, vol.64, issue.5, pp.396-421, 2012.

R. Fule and P. Amin, Development and evaluation of lafutidine solid dispersion via hot melt extrusion: investigating drug-polymer miscibility with advanced characterisation, Asian J. Pharm. Sci, vol.9, issue.2, pp.92-106, 2014.

F. Meng, V. Dave, and H. Chauhan, Qualitative and quantitative methods to determine miscibility in amorphous drug-polymer systems, Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci, vol.77, pp.106-111, 2015.

C. Donnelly, Y. Tian, C. Potter, D. S. Jones, and G. P. Andrews, Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory, Pharm. Res, vol.32, issue.1, pp.167-179, 2015.

Z. M. Lavra, D. Pereira-de-santana, and M. I. Ré, Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus, Drug Dev. Ind. Pharm, vol.43, issue.1, pp.42-54, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01619242

Y. Lan, N. Ali, and . Langley, Characterization of Soluplus® by FTIR and Raman Spectroscopy, 2010.

F. Qian, Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?, Int. J. Pharm, vol.395, issue.1-2, pp.232-235, 2010.